Variant report

Variant	nsv875811
Chromosome Location	chr2:213200920-213347104
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:543)
CpG islands
(count:183)
Chromatin interactive
region (count:17)
LncRNA
region (count:0)
Mature miRNA
region (count: 1)
miRNA target
sites (count:0)

(count:543 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:213288860-213289080	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:213224153-213224545	HepG2	liver:	n/a	n/a
3	ARID3A	chr2:213313548-213313878	HepG2	liver:	n/a	n/a
4	ARID3A	chr2:213316375-213316996	HepG2	liver:	n/a	n/a
5	ATF3	chr2:213316535-213316821	HCT-116	colon:	n/a	n/a
6	ATF3	chr2:213316506-213316722	HepG2	liver:	n/a	n/a
7	ATF3	chr2:213316396-213316830	HepG2	liver:	n/a	n/a
8	BACH1	chr2:213342070-213342161	H1-hESC	embryonic stem cell:	n/a	n/a
9	BATF	chr2:213330212-213330484	GM12878	blood:	n/a	chr2:213330364-213330375
10	BCL11A	chr2:213293765-213294070	H1-hESC	embryonic stem cell:	n/a	n/a
11	BHLHE40	chr2:213316508-213316845	HepG2	liver:	n/a	n/a
12	BHLHE40	chr2:213224318-213224388	HepG2	liver:	n/a	n/a
13	CEBPB	chr2:213316458-213316869	HepG2	liver:	n/a	chr2:213316636-213316647
14	CEBPB	chr2:213253278-213253564	HepG2	liver:	n/a	n/a
15	CEBPB	chr2:213286777-213287045	A549	lung:	n/a	n/a
16	CEBPB	chr2:213316471-213316823	IMR90	lung:	n/a	chr2:213316636-213316647
17	CEBPB	chr2:213209329-213209566	A549	lung:	n/a	chr2:213209437-213209454 chr2:213209442-213209453 chr2:213209440-213209451
18	CEBPB	chr2:213341543-213341622	K562	blood:	n/a	chr2:213341572-213341583
19	CEBPB	chr2:213240564-213240940	IMR90	lung:	n/a	n/a
20	CEBPB	chr2:213316394-213316953	ECC-1	luminal epithelium:	n/a	chr2:213316636-213316647
21	CEBPB	chr2:213271036-213271238	HepG2	liver:	n/a	chr2:213271134-213271147
22	CEBPB	chr2:213341421-213341739	IMR90	lung:	n/a	chr2:213341572-213341583
23	CEBPB	chr2:213340349-213340389	HepG2	liver:	n/a	chr2:213340367-213340378
24	CEBPB	chr2:213302550-213302702	HepG2	liver:	n/a	chr2:213302635-213302646
25	CEBPB	chr2:213316512-213316739	HepG2	liver:	n/a	chr2:213316636-213316647
26	CEBPB	chr2:213209362-213209592	HepG2	liver:	n/a	chr2:213209437-213209454 chr2:213209442-213209453 chr2:213209440-213209451
27	CEBPB	chr2:213309343-213309393	HepG2	liver:	n/a	chr2:213309366-213309377
28	CEBPB	chr2:213341412-213341751	HepG2	liver:	n/a	chr2:213341572-213341583
29	CEBPB	chr2:213240595-213240973	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr2:213224251-213224578	HepG2	liver:	n/a	chr2:213224544-213224556
31	CEBPB	chr2:213316503-213316868	ECC-1	luminal epithelium:	n/a	chr2:213316636-213316647
32	CEBPB	chr2:213316478-213316816	H1-hESC	embryonic stem cell:	n/a	chr2:213316636-213316647
33	CEBPB	chr2:213316456-213317006	Hela-S3	cervix:	n/a	chr2:213316636-213316647
34	CEBPB	chr2:213209433-213209436	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr2:213316458-213317006	A549	lung:	n/a	chr2:213316636-213316647
36	CEBPB	chr2:213316493-213316769	HepG2	liver:	n/a	chr2:213316636-213316647
37	CEBPB	chr2:213316431-213316834	HepG2	liver:	n/a	chr2:213316636-213316647
38	CEBPB	chr2:213209262-213209565	IMR90	lung:	n/a	chr2:213209320-213209329 chr2:213209437-213209454 chr2:213209320-213209329 chr2:213209442-213209453 chr2:213209440-213209451
39	CEBPB	chr2:213240458-213240973	A549	lung:	n/a	n/a
40	CEBPB	chr2:213240450-213241002	HepG2	liver:	n/a	n/a
41	CEBPB	chr2:213341473-213341740	A549	lung:	n/a	chr2:213341572-213341583
42	CEBPD	chr2:213316501-213316725	HepG2	liver:	n/a	n/a
43	CTCF	chr2:213332420-213332570	GM06990	blood:	n/a	n/a
44	CTCF	chr2:213332320-213332470	GM12866	blood:	n/a	n/a
45	CTCF	chr2:213332420-213332570	GM12868	blood:	n/a	n/a
46	CTCF	chr2:213286680-213286830	AG10803	skin:	n/a	n/a
47	CTCF	chr2:213267180-213267330	NHDF-neo	bronchial:	n/a	n/a
48	CTCF	chr2:213267159-213267287	Hela-S3	cervix:	n/a	n/a
49	CTCF	chr2:213332425-213332481	GM13977	blood:	n/a	n/a
50	CTCF	chr2:213332400-213332550	GM12872	blood:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:213292541-213292591	U87	brain:	n/a
2	chr2:213228956-213229006	HNPCEpiC	eye:	n/a
3	chr2:213292541-213292591	SK-N-SH_RA	brain:	n/a
4	chr2:213248884-213248934	PrEC	prostate:	n/a
5	chr2:213292541-213292591	NHDF-neo	bronchial:	n/a
6	chr2:213292541-213292591	GM12878	blood:	n/a
7	chr2:213292541-213292591	MCF-7	breast:	n/a
8	chr2:213228956-213229006	ovcar-3	ovarian:	n/a
9	chr2:213292541-213292591	HUVEC	blood vessel:	n/a
10	chr2:213228956-213229006	Hepatocyte	liver:	n/a
11	chr2:213248884-213248934	BE2_C	brain:	n/a
12	chr2:213292541-213292591	HCT-116	colon:	n/a
13	chr2:213292541-213292591	HMEC	breast:	n/a
14	chr2:213228956-213229006	HCT-116	colon:	n/a
15	chr2:213248884-213248934	HMEC	breast:	n/a
16	chr2:213248884-213248934	MCF-7	breast:	n/a
17	chr2:213248884-213248934	HepG2	liver:	n/a
18	chr2:213228956-213229006	NHDF-neo	bronchial:	n/a
19	chr2:213248884-213248934	HIPEpiC	eye:	n/a
20	chr2:213228956-213229006	GM06990	blood:	n/a
21	chr2:213248884-213248934	SAEC	small airway:	n/a
22	chr2:213292541-213292591	HRE	kidney:	n/a
23	chr2:213228956-213229006	SKMC	muscle:	n/a
24	chr2:213292541-213292591	NHBE	bronchial:	n/a
25	chr2:213228956-213229006	HL-60	blood:	n/a
26	chr2:213248884-213248934	BJ	skin:	n/a
27	chr2:213292541-213292591	CMK	blood:	n/a
28	chr2:213248884-213248934	AG04449	skin:	fetal
29	chr2:213248884-213248934	GM19239	blood:	n/a
30	chr2:213228956-213229006	ProgFib	skin:	n/a
31	chr2:213248884-213248934	PFSK-1	brain:	n/a
32	chr2:213248884-213248934	IMR90	lung:	fetal
33	chr2:213292541-213292591	HNPCEpiC	eye:	n/a
34	chr2:213292541-213292591	K562	blood:	n/a
35	chr2:213228956-213229006	HRPEpiC	eye:	n/a
36	chr2:213228956-213229006	HAEpiC	amniotic membrane:	n/a
37	chr2:213248884-213248934	RPTEC	kidney:	n/a
38	chr2:213248884-213248934	GM12878	blood:	n/a
39	chr2:213248884-213248934	AG09319	gingival:	n/a
40	chr2:213228956-213229006	PrEC	prostate:	n/a
41	chr2:213292541-213292591	LNCaP	prostate:	n/a
42	chr2:213292541-213292591	AG09319	gingival:	n/a
43	chr2:213248884-213248934	GM12891	blood:	n/a
44	chr2:213228956-213229006	MCF-7	breast:	n/a
45	chr2:213292541-213292591	H1-hESC	embryonic stem cell:	embryo
46	chr2:213248884-213248934	U87	brain:	n/a
47	chr2:213228956-213229006	GM12892	blood:	n/a
48	chr2:213248884-213248934	GM06990	blood:	n/a
49	chr2:213292541-213292591	HepG2	liver:	n/a
50	chr2:213248884-213248934	AoSMC	blood vessel:	n/a

(count:17 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:213217638..213221383-chr2:213223310..213226579,3	MCF-7	breast:
2	chr2:213202563..213204297-chr2:213206010..213208677,2	K562	blood:
3	chr2:213217638..213221383-chr2:213223310..213226579,3	MCF-7	breast:
4	chr2:213223218..213224821-chr2:213227410..213229033,2	MCF-7	breast:
5	chr2:213338459..213340893-chr2:213342035..213345641,3	MCF-7	breast:
6	chr2:213213790..213216008-chr2:213223245..213225984,2	MCF-7	breast:
7	chr2:213294886..213296406-chrX:142860992..142862514,2	K562	blood:
8	chr2:213252657..213254943-chr2:213260775..213262754,2	K562	blood:
9	chr2:213338459..213340893-chr2:213342035..213345641,3	MCF-7	breast:
10	chr2:213252657..213254943-chr2:213260775..213262754,2	K562	blood:
11	chr2:213202563..213204297-chr2:213206010..213208677,2	K562	blood:
12	chr2:213213790..213216008-chr2:213223245..213225984,2	MCF-7	breast:
13	chr2:213280702..213283541-chr2:213286415..213289040,2	MCF-7	breast:
14	chr2:213346530..213348548-chr2:213350642..213352540,2	MCF-7	breast:
15	chr2:213280702..213283541-chr2:213286415..213289040,2	MCF-7	breast:
16	chr2:213223218..213224821-chr2:213227410..213229033,2	MCF-7	breast:
17	chr2:23609593..23610480-chr2:213341871..213342572,2	MCF-7	breast:

No data

miRNA name	Chromosome Location	mirBase accession
hsa-miR-548f-3p	chr2:213291008-213291026	MIMAT0005895_1

No data

Variant related genes	Relation type
MIR548F2	TF binding region
ERBB4	TF binding region
MIR548F2	CpG island
ERBB4	CpG island

Extended variants
information (count: 5226 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:5226 , 50 per page) page: 1 2 3 4 5 6 7 ... 105

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1394782	chr2:213200920-213200921	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs368757705	chr2:213200924-213200925	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs76419527	chr2:213200976-213200977	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs190064491	chr2:213200978-213200979	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs554229006	chr2:213201012-213201013	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs574135674	chr2:213201029-213201030	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs539844766	chr2:213201053-213201054	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs73987370	chr2:213201112-213201113	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs182714809	chr2:213201127-213201128	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs545646944	chr2:213201140-213201141	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs149348744	chr2:213201162-213201163	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs549762704	chr2:213201202-213201203	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs375206244	chr2:213201257-213201258	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs146403651	chr2:213201274-213201275	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs61696052	chr2:213201295-213201296	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs186728927	chr2:213201311-213201312	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs561356306	chr2:213201323-213201324	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs73987371	chr2:213201375-213201376	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs546689676	chr2:213201409-213201410	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs139747123	chr2:213201481-213201482	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs532328933	chr2:213201492-213201493	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs552033197	chr2:213201553-213201554	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs371869186	chr2:213201565-213201566	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs143002253	chr2:213201566-213201567	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs66494816	chr2:213201567-213201568	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs568747454	chr2:213201592-213201593	Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs12623803	chr2:213201642-213201643	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs554290566	chr2:213201653-213201654	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs77551691	chr2:213201680-213201681	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs533844981	chr2:213201705-213201706	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs1394783	chr2:213201725-213201726	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs576744036	chr2:213201728-213201729	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs191578115	chr2:213201764-213201765	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs545404014	chr2:213201836-213201837	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs142979631	chr2:213201862-213201863	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs575948823	chr2:213201904-213201905	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs555241848	chr2:213202015-213202016	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs544813834	chr2:213202027-213202028	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs561429671	chr2:213202041-213202042	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs533112597	chr2:213202070-213202071	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs530154435	chr2:213202072-213202073	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs569303425	chr2:213202090-213202091	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs75383791	chr2:213202104-213202105	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs113853722	chr2:213202156-213202157	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs74567775	chr2:213202163-213202164	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs115291789	chr2:213202164-213202165	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs538396028	chr2:213202175-213202176	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs146112196	chr2:213202202-213202203	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs73070304	chr2:213202226-213202227	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs568211784	chr2:213202278-213202279	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Non-small cell lung cancer	21829676	CNVD
Autism	20808228	CNVD
Renal cell carcinoma	18765545	CNVD
Ovarian cancer	19193619	CNVD
Non-small cell lung cancer	18676828	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Urothelial cell carcinoma	18451213	CNVD
Developmental delay	21147756	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	18990708	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:632 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:213195400-213201400	Weak transcription	Brain Cingulate Gyrus	brain
2	chr2:213195400-213201400	Weak transcription	Brain Inferior Temporal Lobe	brain
3	chr2:213195600-213201200	Weak transcription	Brain Angular Gyrus	brain
4	chr2:213195600-213201400	Weak transcription	Brain Hippocampus Middle	brain
5	chr2:213195600-213201800	Weak transcription	Brain Substantia Nigra	brain
6	chr2:213195800-213201400	Weak transcription	Aorta	Aorta
7	chr2:213195800-213201600	Weak transcription	Fetal Heart	heart
8	chr2:213201000-213202000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr2:213201000-213203000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
10	chr2:213201200-213202400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr2:213201200-213202400	Enhancers	Brain Angular Gyrus	brain
12	chr2:213201200-213203200	Enhancers	Breast Myoepithelial Primary Cells	Breast
13	chr2:213201400-213201600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr2:213201400-213201600	Enhancers	Brain Cingulate Gyrus	brain
15	chr2:213201400-213201600	Enhancers	Brain Inferior Temporal Lobe	brain
16	chr2:213201400-213201800	Active TSS	Aorta	Aorta
17	chr2:213201400-213202600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr2:213201400-213203000	Enhancers	Brain Hippocampus Middle	brain
19	chr2:213201400-213203200	Enhancers	Brain Anterior Caudate	brain
20	chr2:213201600-213202000	Weak transcription	Brain Cingulate Gyrus	brain
21	chr2:213201600-213202200	Weak transcription	Brain Inferior Temporal Lobe	brain
22	chr2:213201600-213202600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr2:213201600-213203200	Enhancers	Fetal Heart	heart
24	chr2:213201800-213202200	Enhancers	Brain Substantia Nigra	brain
25	chr2:213201800-213213000	Weak transcription	Aorta	Aorta
26	chr2:213202000-213202400	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr2:213202000-213203000	Enhancers	Brain Cingulate Gyrus	brain
28	chr2:213202200-213202600	Flanking Active TSS	Brain Substantia Nigra	brain
29	chr2:213202200-213203000	Enhancers	Brain Inferior Temporal Lobe	brain
30	chr2:213202200-213203200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr2:213202400-213203200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr2:213202400-213204400	Weak transcription	Brain Angular Gyrus	brain
33	chr2:213202600-213202800	Enhancers	Brain Substantia Nigra	brain
34	chr2:213202600-213203400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr2:213202600-213204800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr2:213203200-213208000	Weak transcription	Fetal Heart	heart
37	chr2:213204400-213204600	Enhancers	Brain Angular Gyrus	brain
38	chr2:213204800-213205600	ZNF genes & repeats	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr2:213205200-213205400	ZNF genes & repeats	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr2:213205600-213221000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
41	chr2:213208000-213210800	Enhancers	Fetal Heart	heart
42	chr2:213209000-213209200	Enhancers	Adipose Nuclei	Adipose
43	chr2:213210800-213211200	Weak transcription	Fetal Heart	heart
44	chr2:213211000-213211600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr2:213211200-213216200	Enhancers	Fetal Heart	heart
46	chr2:213212800-213213200	Enhancers	ES-I3 Cell Line	embryonic stem cell
47	chr2:213213000-213213400	Active TSS	Aorta	Aorta
48	chr2:213213200-213214800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
49	chr2:213213400-213213600	Flanking Active TSS	Aorta	Aorta
50	chr2:213213600-213215600	Weak transcription	Aorta	Aorta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links